Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

التفاصيل البيبلوغرافية
العنوان:	Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
المؤلفون:	Mateos, MV, Nahi, H, Legiec, W, Grosicki, S, Vorobyev, V, Spicka, I, Hungria, V, Korenkova, S, Bahlis, N, Flogegard, M, Blade, J, Moreau, P, Kaiser, M, Iida, S, Laubach, J, Magen, H, Cavo, M, Hulin, C, White, D, De Stefano, V, Clemens, PL, Masterson, T, Lantz, K, O'Rourke, L, Heuck, C, Qin, X, Parasrampuria, DA, Yuan, ZL, Xu, S, Qi, M, Usmani, SZ
المصدر:	The Lancet. Haematology. 7(5):E370-E380
مصطلحات موضوعية:	Medicin och hälsovetenskap
URL الوصول:	http://kipublications.ki.se/Default.aspx?queryparsed=id:143607187
قاعدة البيانات:	SwePub

الوصف
تدمد:	23523026
DOI:	10.1016/S2352-3026(20)30070-3